Add Idarucizumab To Your DOAC Reversal Protocol for Dabigatran

Idarucizumab eye-DAIR-yoo-siz-ooh-mab, Praxbind) will be the first reversal agent for ONE of the direct oral anticoagulants (DOACs).

It's an IV monoclonal antibody fragment that binds to the thrombin inhibitor, dabigatran (Pradaxa), to reverse anticoagulation.

But idarucizumab won't work for factor Xa inhibitors...rivaroxaban (Xarelto), apixaban (Eliquis), or edoxaban (Savaysa)...or other direct thrombin inhibitors like argatroban.